Given the size of the stroke depicted in Figure 1 (greater than one third of the hemisphere), thrombolytic therapy would be contraindicated for this patient. Indications of a hemorrhagic stroke ...

When Joseph Broderick was a college sophomore in 1975, stroke treatment was a waiting game. Doctors could diagnose a stroke but couldn’t stop it. There were no scientifically proven therapies, no ...

Royal United Hospitals Bath (RUH Bath) has launched a recruitment drive for isosorbide mononitrate and cilostazol trials – ...

Prompt, intensive blood pressure lowering within days of a TIA or minor stroke cuts recurrent stroke rates, results of a ...

Potential clinical uses included emergency stroke therapy, as an adjunct to rehabilitation, and as a neuroprotective agent, which may expand the treatment’s relevance to traumatic brain injury and ...

A stroke occurs when blood flow to the brain is interrupted, either by a blockage or bleeding in the blood vessels. This disruption deprives brain cells of oxygen, causing them to die. The impact of a ...

Patients who undergo general anesthesia while receiving a specialized surgery to treat strokes have better outcomes than ...

For more than 40 years as a researcher and clinician, Joseph Broderick has actively contributed to improvements in stroke ...

Corresponding author Akshay Sharma, MBBS, MSc, St. Jude Department of Bone Marrow Transplantation and Cellular Therapy talks to St. Jude patient enrolled on the reported clinical trial, Corey Luellen.

Dublin, Oct. 22, 2025 (GLOBE NEWSWIRE) -- The "Acute Ischemic Stroke - Pipeline Insight, 2025" has been added to ResearchAndMarkets.com's offering. The "Acute Ischemic Stroke - Pipeline Insight, 2025" ...